PCOS Diagnosis With AMH Test Possible

"Do I really have to do an ultrasound? I heard it can be diagnosed with just a blood test (AMH)." It is a question I hear noticeably more often in the clinic. In fact, there has recently been a meaningful change in the diagnostic criteria for polycystic ovary syndrome (PCOS). However, if you only know that AMH came in as a "test that replaces ultrasound" and miss its use and limitations, it can rather easily lead to unnecessary tests or a hasty diagnosis. In this article, we organize how AMH came into the diagnostic criteria and in which cases it should not be applied.

Polycystic ovary syndrome is not a disease that can be told apart at once by one test value. The international guideline recommends diagnosing PCOS in adults when two or more of the following three are confirmed.

• Clinical or biochemical hyperandrogenism (hirsutism, acne, or elevated blood male hormone)
• Ovulatory dysfunction or an irregular menstrual cycle
• Polycystic ovarian morphology, that is, PCOM (the polycystic appearance of the ovary)

The key here is the structure of "two out of three." That is, ovarian morphology (PCOM) is only one of several axes used in diagnosis, and is not itself the whole of the disease. In the clinic, many people fixate only on the single AMH value and ask "Do I have PCOS?", but the actual diagnosis is a comprehensive judgment made by tying together symptoms, hormones, and imaging findings. The reason you should not vaguely dismiss menstrual irregularity is covered in more detail in why you should not neglect menstrual irregularity.

The most changed point is that, when judging ovarian morphology (PCOM) in adults, blood AMH measurement can be used as an option instead of ultrasound. The international evidence-based PCOS guideline published in 2023 explicitly added AMH measurement as an alternative to gynecological ultrasound (International Evidence-based PCOS Guideline, 2023). The intent of this change is clear. Until now, confirming PCOM in effect depended on transvaginal ultrasound at obstetrics-gynecology and fertility clinics, but it lowered the threshold so that the diagnostic process could be started with a single blood draw even in other areas such as primary care or internal medicine.

However, the expression must be precise. AMH came in as "another method of evaluating PCOM, one of the three criteria," not as "a standalone test that replaces the PCOS diagnosis itself." The guideline does not support using AMH as a standalone marker of PCOS, and clearly states that when used as a single marker, its sensitivity and specificity decline (International Evidence-based PCOS Guideline, 2023). Letting this difference slip by creates the misunderstanding that "if only AMH is high, it is PCOS."

Interestingly, not every patient has to go through ultrasound or AMH testing. If both irregular menstruation and hyperandrogenism are distinct, and all other underlying diseases causing similar symptoms have been excluded, then the "two out of three" condition is already satisfied, so a diagnosis is possible even without confirming ovarian morphology.

In clinical experience, many people feel relieved when this point is explained. This is because the key is not that doing more tests makes the diagnosis more accurate, but choosing only the needed test after seeing which criterion is empty. Which test to look at first when symptoms are ambiguous, such as amenorrhea, is organized in the tests needed when you do not have periods.

The most important exception in applying AMH for diagnosis is precisely adolescents. The 2023 guideline recommends not using either AMH or ultrasound for judging PCOM within about 8 years after menarche (International Evidence-based PCOS Guideline, 2023). This is because around puberty, the ovaries commonly show a polycystic shape or AMH comes out high even normally, so specificity is low.

So in adolescents, the axis of diagnosis differs. Instead of ovarian morphology, whether persistent anovulation (irregular menstruation) and hyperandrogenism are confirmed together is examined. In the clinic, many parents worry, saying "my daughter has a lot of hair and severe acne, isn't it PCOS?", but in this period it is safer to avoid a hasty diagnosis and observe the course over time. The following table organizes the difference in approach between adults and adolescents.

If you have questions, please inquire by chat consultation about the test that fits your symptoms.

Although AMH is a convenient test, it is not a test that can judge everyone by a single absolute cutoff value. The guideline and subsequent analyses point out that there is no standardized single reference value for AMH measurement, and recommend using different cutoff values for each laboratory and assay (Piltonen et al., 2024). In fact, even the same blood can give different values depending on which analysis instrument measured it.

There are also several factors that affect the AMH value itself.

• Age (a tendency to generally decrease with age)
• Body mass index (BMI)
• Oral contraceptives being taken
• Surgical history, the cycle day on which it was measured

So if "I am taking the pill and AMH came out low," it is reasonable to consider the possibility of the drug's influence and reassess by changing whether to discontinue it or the timing of the test. It means that, rather than collectively concluding the effect of hormonal agents on test results as a drug effect, the individual's situation should be examined together. For cases where metabolic factors are intertwined, like the link between weight and amenorrhea, the connection between weight gain and amenorrhea is also a reference.

That AMH came in as an alternative does not mean the place of ultrasound has disappeared. When trying to directly confirm ovarian morphology in adults, transvaginal ultrasound is reported as the most accurate method. Criteria such as ovarian volume are used in judging PCOM, and that reference value can differ depending on the instrument and approach used.

In summary, in adults, when confirming PCOM, you may choose whichever of ultrasound and AMH suits the situation. If the environment makes blood drawing convenient, you can start with AMH, and if you need to look at the ovary itself in detail or confirm other gynecological findings together, ultrasound may be more suitable. For any test, the result has meaning only when interpreted together with symptoms and hormone findings. How to update the diagnostic basis with the latest research continues in the latest paper update on polycystic ovary syndrome.

Q. If only AMH is high, is it PCOS? No. AMH standalone diagnosis is not recommended. The principle is to synthesize clinical, hormone, and imaging findings. Q. I am taking the pill and AMH came out low. There is a possibility of the drug's influence, so it is better to reassess considering whether to discontinue and the timing of the test. Q. My adolescent daughter has severe hair and acne, is it PCOS? Adolescents have different diagnostic criteria and AMH/ultrasound are not used for diagnosis, so symptom management and course observation take priority over a hasty diagnosis.

AMH is a useful tool that has broadened the options for PCOS diagnosis. However, if you look only at the value without context, there is a risk of misdiagnosis. Looking at your age, the medications you are taking, the menstrual cycle, and accompanying symptoms all at once is the key to diagnosis. If interpreting the test results or the next step feels overwhelming, please receive a consultation below.

Author: Lee Dong-hee Chief Director · Obstetrician-Gynecologist · View staff profile

First published September 30, 2025 · Last reviewed May 30, 2026

References: International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023), Piltonen et al. (2024)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical examination.